Mouse Study Pairs Tirzepatide With Fasting and Strength Training

A new animal study in the Journal of Physiology looked at how tirzepatide performs when paired with lifestyle interventions in obese female mice, according to the PubMed listing. Researchers induced obesity in female Swiss mice over 10 weeks, then treated them for 8 weeks with tirzepatide alone, time restricted feeding alone, resistance training alone, or combinations of all three.

Tirzepatide alone reduced body weight gain and feed efficiency, consistent with a negative energy balance. When researchers added a 12 hour feeding window and stair climbing resistance sessions, weight loss accelerated, bringing body weight close to levels seen in lean control mice. The combined approach also reduced adipose mass and adipocyte hypertrophy, and resistance training preserved skeletal muscle mass that might otherwise be lost during rapid weight loss.

Glucose tolerance improved most when tirzepatide was paired with time restricted feeding, whether or not resistance training was included. All of the interventions tested, alone or combined, similarly reduced hepatic lipid accumulation and related gene expression, suggesting no added liver benefit from stacking strategies.

This is a mouse study, not human research, and tirzepatide here was used as approved for metabolic research purposes in an animal model rather than in people. Whether these combined effects translate to human physiology remains to be tested.

This article is for education only. It is not medical advice. Compounds discussed here are sold for research purposes. Talk to a licensed clinician before making health decisions.